Terms ending in 2030
Every in-force patent on Georgetown University's record whose computed term ends in 2030, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 8,637,556 | Linked Myc-Max Small Molecule Inhibitors In force · High confidence | University of Pittsburgh - of the Commonwealth System of Higher Education | In force | High confidence | |
| US 9,284,368 | Substituted Pyrazines as CADHERIN-11 Inhibitors In force · High confidence | Georgetown University | In force | High confidence | |
| US 9,889,131 | Cadherin-11 Inhibitors and Methods of Use Thereof In force · High confidence | Georgetown University | In force | High confidence | |
| US 8,881,040 | System and Method for Detecting, Collecting, Analyzing, and Communicating Event-Related Information In force · High confidence | Georgetown University | In force | High confidence | |
| US 9,012,142 | Sequence-Specific Detection of Nucleotide Sequences In force · Medium confidence | Georgetown University | In force | Medium confidence | |
| US 10,002,034 | System and Method for Detecting, Collecting, Analyzing, and Communicating Event-Related Information In force · High confidence | Georgetown University | In force | High confidence | |
| US 9,682,094 | Targeting Matriptase Expressing Tumor Cells with Chemotherapeutic Agents Conjugated to Matriptase Antibodies In force · High confidence | Georgetown University | In force | High confidence | |
| US 9,849,192 | Targeting Tumor Cells with Chemotherapeutic Agents Conjugated to Matriptase Antibodies In force · High confidence | Georgetown University | In force | High confidence | |
| US 10,376,597 | Targeting Tumor Cells with Chemotherapeutic Agents Conjugated to Matriptase Antibodies In force · High confidence | Georgetown University | In force | High confidence | |
| US 11,752,215 | Targeting Tumor Cells with Chemotherapeutic Agents Conjugated to Anti-Matriptase Antibodies by in Vivo Cleavable Linking Moieties In force · High confidence | Rutgers, the State University of New Jersey | In force | High confidence |
10 of 10 patents shown. Soonest term end first, then patent number.
8 of these are in force and held by Georgetown University.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.